Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIND Therapeutics Inc (NASDAQ:BIND)

0.7815
Delayed Data
As of Jul 29
 -0.0885 / -10.17%
Today’s Change
0.35
Today|||52-Week Range
5.25
-65.87%
Year-to-Date
No recent news for BIND Therapeutics Inc.

Today’s Trading

Previous close0.87
Today’s open0.77
Day’s range0.69 - 0.83
Volume2,474,776
Average volume (3 months)879,443
Market cap$16.3M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+8.12%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+47.72%
P/E ratioNM
Price/Sales3.01
Price/Book0.95

Competitors

 Today’s
change
Today’s
% change
CSBRChampions Oncology I...-0.04-2.00%
RXIIRxi Pharmaceuticals ...-0.02-0.84%
WGBSWaferGen Bio-systems...+0.01+1.02%
SNGXSoligenix Inc0.000.00%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$15.4M
Annual profit (last year)-$36.6M
Net profit margin-237.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Vice President-Discovery &
Research
Stephen Zale
Chief Medical Officer
Hagop Youssoufian
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs